Free Trial
NASDAQ:GRAL

GRAIL Q2 2025 Earnings Report

GRAIL logo
$32.96 -0.12 (-0.36%)
Closing price 08/7/2025 04:00 PM Eastern
Extended Trading
$32.75 -0.21 (-0.64%)
As of 07:26 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GRAIL EPS Results

Actual EPS
N/A
Consensus EPS
-$3.14
Beat/Miss
N/A
One Year Ago EPS
N/A

GRAIL Revenue Results

Actual Revenue
N/A
Expected Revenue
$37.57 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

GRAIL Announcement Details

Quarter
Q2 2025
Time
After Market Closes
Conference Call Date
Tuesday, August 12, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

GRAIL Earnings Headlines

Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...
See More GRAIL Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like GRAIL? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GRAIL and other key companies, straight to your email.

About GRAIL

GRAIL (NASDAQ:GRAL) operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

View GRAIL Profile

More Earnings Resources from MarketBeat